Updates in CRC: Applying Evidence to Clinical Practice - Episode 7

Final Insights: Emerging role of MRD and ctDNA testing in Colon Cancer

Panelists discuss how Minimal Residual Disease (MRD) and circulating tumor DNA (ctDNA) testing are revolutionizing colon cancer management through improved risk stratification, treatment selection, and surveillance strategies.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Starting with a Patient Case: 45yM high-risk T4N0 resected CRC - What are next steps?
    EP. 2: Patient Centered Approach: Important Patient Counseling Points regarding ctDNA results in CRC
    EP. 3: Expert Perspectives: GALAXY Results from CIRUCLATE study - Is it Practice Changing?
    EP. 4: Understanding ctDNA in Resected CRC: Transient vs. Sustained Clearance & Clinical Implications
    EP. 5: Practical Considerations: Complexities with Utilizing ctDNA in CRC in the Real-World Practice Setting
    EP. 6: Exploring the NICHE-2 Trial: Neoadjuvant Immunotherapy in dMMR Colon Cancer
    Now Viewing
    EP. 7: Final Insights: Emerging role of MRD and ctDNA testing in Colon Cancer

    x